At molecular level, changes in the proliferation/apoptosis balance were associated with decrease of Bcl2 expression in VP treated groups with or without inflammatory conditions (Figure 3G) and in YAP siRNA RA FLS with inflammatory conditions (Supplementary Figure 2B). Here, BCL2 is linked to rheumatoid arthritis.